{
  "cik": 1710072,
  "cik_padded": "0001710072",
  "entityName": "Edgewise Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001104659-26-020112",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 256000.0,
        "cash": 61148000.0,
        "eps_diluted": -1.63,
        "free_cash_flow": -144072000.0,
        "net_income": -167795000.0,
        "operating_cash_flow": -143816000.0,
        "operating_income": -191406000.0,
        "stockholders_equity": 522257000.0,
        "total_assets": 552603000.0,
        "total_liabilities": 30346000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05810549212360964,
        "roa_avg2y": -0.3228627503800196,
        "roa_period_end": -0.30364475039042493,
        "roe_avg2y": -0.3419248415391967,
        "roe_period_end": -0.3212881780426112
      }
    },
    {
      "accn": "0001104659-26-020112",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1312000.0,
        "cash": 41666000.0,
        "eps_diluted": -1.45,
        "free_cash_flow": -110340000.0,
        "net_income": -133813000.0,
        "operating_cash_flow": -109028000.0,
        "operating_income": -158832000.0,
        "stockholders_equity": 459216000.0,
        "total_assets": 486817000.0,
        "total_liabilities": 27601000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.060104613079683636,
        "roa_avg2y": -0.3236685646282527,
        "roa_period_end": -0.27487330968310475,
        "roe_avg2y": -0.3439719502445871,
        "roe_period_end": -0.2913944636075398
      }
    },
    {
      "accn": "0001558370-25-002006",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5745000.0,
        "cash": 86097000.0,
        "eps_diluted": -1.57,
        "free_cash_flow": -97693000.0,
        "net_income": -100163000.0,
        "operating_cash_flow": -91948000.0,
        "operating_income": -114357000.0,
        "stockholders_equity": 318830000.0,
        "total_assets": 340035000.0,
        "total_liabilities": 21205000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06650879779192673,
        "roa_avg2y": -0.28329204000362024,
        "roa_period_end": -0.2945667357771994,
        "roe_avg2y": -0.3009949725488546,
        "roe_period_end": -0.31415801524323306
      }
    },
    {
      "accn": "0001558370-24-001467",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5546000.0,
        "cash": 21993000.0,
        "eps_diluted": -1.26,
        "free_cash_flow": -58181000.0,
        "net_income": -67640000.0,
        "operating_cash_flow": -52635000.0,
        "operating_income": -71658000.0,
        "stockholders_equity": 346716000.0,
        "total_assets": 367101000.0,
        "total_liabilities": 20385000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05879451770324992,
        "roa_avg2y": -0.207378428841667,
        "roa_period_end": -0.1842544694784269,
        "roe_avg2y": -0.2178074670865675,
        "roe_period_end": -0.19508762214607922
      }
    },
    {
      "accn": "0001558370-24-001467",
      "filed": "2024-02-22",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 668000.0,
        "cash": 15566000.0,
        "eps_diluted": -1.14,
        "free_cash_flow": -34175000.0,
        "net_income": -42813000.0,
        "operating_cash_flow": -33507000.0,
        "operating_income": -43215000.0,
        "stockholders_equity": 274383000.0,
        "total_assets": 285233000.0,
        "total_liabilities": 10850000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.03954326616444896,
        "roa_avg2y": -0.20564931587125843,
        "roa_period_end": -0.15009834065483307,
        "roe_avg2y": -0.3553491614895233,
        "roe_period_end": -0.15603371929018925
      }
    },
    {
      "accn": "0001558370-23-001895",
      "filed": "2023-02-23",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 203000.0,
        "cash": 104916000.0,
        "eps_diluted": -23.17,
        "free_cash_flow": -14837000.0,
        "net_income": -17123000.0,
        "operating_cash_flow": -14634000.0,
        "operating_income": -17192000.0,
        "stockholders_equity": -33420000.0,
        "total_assets": 131136000.0,
        "total_liabilities": 4342000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.13057436554416788,
        "roe_avg2y": 0.681200644481133
      }
    },
    {
      "accn": "0001558370-22-001850",
      "filed": "2022-02-24",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -16853000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001104659-26-020112",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001710072.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001710072.json"
  },
  "ticker": "EWTX"
}